Related by context. All words. (Click for frequent words.) 87 occlusion PAO 79 catheter occlusion 75 Central Retinal Vein 73 Alfimeprase 72 vapreotide acetate 72 central retinal vein 72 Phase 2b Clinical Trial 72 Microplasmin 71 Meets Primary Endpoint 71 PEGylated Fab fragment 71 R Saizen R 71 Intravitreal 71 Pivotal Trial 71 Oral Fingolimod 70 Pivotal Phase III 70 Trial Evaluating 70 retinal vein occlusion induced 70 delivers fluocinolone acetonide FA 70 branch retinal vein 70 acetonide FA 70 oral prodrug 70 endoluminal stent graft 70 CYT# potent vascular disrupting 70 Tezampanel 70 topically applied SEPA 69 aneurysms AAA 69 treating abdominal aortic 69 Patients Treated With 69 occlusion CRVO 69 Novel Oral 69 NAVISTAR R 69 Phase 2a Clinical Trial 69 Methylnaltrexone 69 peripheral arterial occlusive disease 69 complement inhibitor eculizumab 69 MKC# MT 69 essential thrombocythemia ET 69 catheter occlusion CO 69 diarrhea fatigue asthenia 69 Refractory Hodgkin Lymphoma 69 occlusive disease 69 TNF Tumor Necrosis Factor 69 metastatic malignant 69 induced macular edema 69 acting thrombolytic 69 vitreoretinal disorders 69 ADP receptor antagonist 69 Pivotal Phase 69 R roscovitine CDK cyclin 69 arthritis PsA 69 dependent kinase inhibitor 69 NASH Huntington 69 Initiates Phase II 68 virus HCV protease inhibitor 68 Personalized Immunotherapy 68 Phase IIb Trial 68 docetaxel Taxotere ® 68 Intravesical 68 Prospective Randomized 68 Completes Patient Enrollment 68 Achieves Primary Endpoint 68 dihydrochloride Tablets 68 TO AVOID PREGNANCY WHILE 68 Study Evaluating 68 mGluR5 negative 68 LymphoStat B belimumab 68 treat benign prostatic 68 PEGylated anti 68 metastatic colorectal 68 Safinamide 68 5 fluorouracil leucovorin 68 modified glutathione analog 68 descending thoracic 68 myocardial infarction ventricular fibrillation 68 prokinetic agent 68 Aflibercept 68 Biolimus A9 68 oropharyngeal candidiasis OPC 68 Combination REOLYSIN R 68 Left Ventricular 68 Eluting Stent 68 Pivotal Study 68 Vitrasert R 68 diarrhea predominant irritable 68 Anti VEGF 68 Bucindolol 68 investigational humanized monoclonal antibody 68 Complicated Skin 68 NU# direct 68 sunitinib Sutent 68 Acute Exacerbations 68 SinuNase TM 68 Hormone Refractory Prostate Cancer 68 Frozen Shoulder syndrome Adhesive 68 superficial femoral 68 Completes Enrollment 68 receiving chemoradiation therapy 68 novel VDA molecule 68 including eniluracil ADH 67 Nebulized 67 Wafer polifeprosan 67 cetuximab Erbitux R 67 Factor VIIa 67 vaginal candidiasis 67 Enzastaurin 67 Endologix Powerlink System 67 lexidronam injection 67 Initiates Enrollment 67 Orally administered 67 dyskinesia PD LID 67 Receives Orphan Drug Designation 67 2 methoxyestradiol 67 Initiate Phase 67 Peripheral Arterial 67 trial evaluating PRX# 67 MTP inhibitor 67 methylnaltrexone bromide 67 Pivotal Clinical Trial 67 Serostim ® 67 sapropterin dihydrochloride 67 ® lenalidomide 67 EnteroMedics proprietary neuroblocking technology 67 Ovitrelle R Serostim 67 INSPIRE Trial Phase III 67 CIMZIA TM certolizumab pegol 67 hypertrichosis occurred 67 sodium thiosulfate STS 67 Diabetic Macular Edema DME 67 Investigational Treatment 67 kidney urologic 67 ribavirin Copegus ® 67 CTAP# 67 systemic anaplastic large 67 Initiates Clinical Trial 67 Tyrosine Kinase Inhibitor 67 sorafenib tablets 67 molecular imaging radiopharmaceutical 67 Adjuvant Treatment 67 IL# PE#QQR 67 Patients Receiving 67 Phase #b/#a clinical 67 chronic thromboembolic pulmonary 67 atypical Hemolytic Uremic Syndrome 67 Hsp# Inhibitor 67 toenail onychomycosis 67 Parkinson disease levodopa induced 67 bone marrow reticulin deposition 67 Clinical Trial Evaluating 67 overactive bladder AA# 67 recurrent glioblastoma multiforme 67 investigational pharmacologically unique 67 alfimeprase direct 67 keloid scarring 67 novel synthetic peptide 67 Efficacy Trial 67 macular edema secondary 67 Phase IIb Clinical Trial 67 treat chronic sinusitis 67 Angiotensin Converting Enzyme 67 Dupuytren Disease 67 INTEGRILIN R 66 Percutaneous Transluminal Coronary Angioplasty 66 hypervascular tumors 66 uricase 66 Phase III Clinical Trial 66 systemically administered 66 rheumatoid arthritis RA psoriatic 66 investigational monoclonal antibody 66 Zorbtive TM 66 Inhalation Solution 66 Kuvan TM sapropterin 66 targeted radiotherapeutic 66 esophageal candidiasis 66 brand ciclesonide HFA 66 Eculizumab 66 PATHFINDER R 66 Fondaparinux 66 thrombolytic agent 66 myelodysplastic myeloproliferative diseases 66 non splenectomized 66 chronic eosinophilic leukemia 66 acute PAO 66 Refractory Angina 66 fosbretabulin 66 II Clinical Trial 66 Cannabinor 66 either acutely decompensated 66 endoluminal stent graft ELG 66 itraconazole Sporanox 66 Randomized Double blind 66 Acute Ischemic Stroke 66 allosteric modulator NAM 66 dihydrochloride 66 Adjunctive 66 investigational antiplatelet agent 66 Intravascular 66 iobenguane 66 Intracranial 66 peripherally acting 66 transthyretin TTR mediated amyloidosis 66 Phase III Trial 66 sorafenib Nexavar 66 Augment TM 66 orally administered inhibitor 66 FOLOTYN ® 66 familial amyloidotic polyneuropathy FAP 66 nephropathic cystinosis 66 Randomized Phase 66 Files IND 66 Ribavirin causes 66 ergot derivatives 66 arterial thrombosis 66 refractory recurrent 66 TKB# 66 peripheral artery 66 FDA APPROVES 66 Opterone R 66 IAP inhibitor 66 potent CYP#A# inhibitors 66 R lenalidomide 66 bevacizumab Avastin ® 66 EVIZON TM 66 renal failure interstitial lung 66 dextromethorphan quinidine 66 acyclovir Lauriad R 66 Patient Enrollment 66 erlotinib Tarceva ® 66 phenylketonuria PKU developed 66 dasatinib Sprycel ® 66 Investigational Oral 66 Ancrod 66 hyperphenylalaninemia HPA due 66 interferon alpha IFN 66 mu opioid receptor antagonist 66 pan HDAC inhibitor 66 Daclizumab 66 Cypher Sirolimus 66 Pericardial 66 mertansine 66 Injectable Bone Graft 66 vinorelbine tartrate 66 recombinant tissue plasminogen 66 orally inhaled 65 aldehyde dehydrogenase ALDH2 deficiency 65 opioid induced bowel dysfunction 65 evaluating picoplatin 65 BCG refractory carcinoma 65 tartrate Inhalation Solution 65 ZOLINZA 65 Phase 2b Study 65 Sapacitabine 65 samarium Sm 65 Bone Graft 65 generation purine nucleoside 65 idiopathic thrombocytopenic purpura ITP 65 HuMax EGFr 65 purpura ITP 65 Pooled Analysis 65 Diabetic Neuropathy 65 INCB# [003] 65 levodopa induced 65 Thiarabine 65 calcipotriene 65 aflibercept VEGF Trap 65 lucinactant 65 deep venous thromboses 65 reslizumab 65 pan histone deacetylase 65 Successfully Treats 65 bevacizumab Avastin R 65 Resten NG 65 coronary stent merged 65 Disease IBD 65 Vicriviroc 65 GEM OS2 65 erythematosus SLE 65 Panzem R 65 interferon beta 1a infertility 65 diarrhea vomiting rash 65 sapropterin dihydrochloride Tablets 65 hypereosinophilic syndrome 65 ALN HPN 65 PRN FDA Approves 65 Dose Ranging Study 65 metastatic neuroendocrine tumors 65 Syndrome LEMS 65 Aneurysm Repair 65 DURECT proprietary 65 Myelodysplastic Syndrome MDS 65 hyaluronidase enzyme 65 nephropathic cystinosis cystinosis 65 headache nasopharyngitis 65 oral nucleoside analogue 65 Seliciclib CYC# 65 hypoxia activated prodrug 65 monoclonal antibody IgG1 Mab 65 fondaparinux sodium 65 refractory gout 65 Mg Usa 65 INS# [001] 65 Dupuytren Contracture 65 bucindolol hydrochloride 65 superficial basal cell carcinoma 65 erosive gastritis 65 MKC# MKC# PP 65 severe malignant osteopetrosis 65 Iluvien ® 65 Sudhir Agrawal D.Phil 65 Lupus Nephritis 65 Romidepsin 65 Clinical Trial Results 65 Embolic Protection 65 ELADUR ™ 65 phase IIb clinical 65 BRIM2 65 TRANSDUR ® 65 Crofelemer budesonide foam 65 migraines neurorehabilitation 65 Phase 2b Trial 65 Pemetrexed 65 Lubiprostone 65 nucleoside analog 65 ALVESCO ® 65 Liprotamase 65 Golimumab 65 oral dual endothelin 65 FDA Approvals 65 benzoic acid hyoscyamine sulfate 65 Renal Artery 65 FUSILEV enhances 65 beta 1a 65 Regenerative Cells 65 Bazedoxifene 65 oral beclomethasone dipropionate 65 TM Drug Eluting 65 uremic pruritus 65 Squalamine 65 unresectable tumors 65 topically administered 65 topical gel formulation 65 Arteriovenous 65 undergoing elective percutaneous 65 Ranolazine 65 SYN# 65 Loceryl ® 65 Commences Phase 65 Phase III Pivotal 65 Occlusive Disease 65 PNP inhibitor 65 J Am Coll 65 EXPAREL TM 65 Solazed TM 65 malignant ascites 65 Ischemic 65 neurogenic bladder 65 mild vasodilator 65 Vascular Disrupting Agent 65 PAOD 65 DG# compounds targeting 65 overactive bladder syndrome 65 Vidaza azacitidine 65 Demonstrates Positive 65 Initiate Clinical Trial 65 radiation enteritis 65 huC# DM4 65 administered concomitantly 65 #mg BID [001] 65 PLX STROKE targeting 65 Excellarate TM 65 metastatic GIST 65 humanized therapeutic 65 antibody MAb 65 Albuferon TM 65 CYP#A# CYP#D# 65 tumor lysis syndrome 65 Friedreich Ataxia FRDA 65 inhibitor PPI 64 Vascugel 64 post operative ileus 64 Known hypersensitivity 64 receptor tyrosine kinase inhibitor 64 thetreatment 64 systemic hypotension 64 selective A2A adenosine receptor 64 Solazed ™ 64 PEGylated interferon beta 1a 64 edifoligide 64 Lisofylline 64 inhibit platelet function 64 induced mucositis 64 Drug Candidate 64 cetuximab Erbitux ® 64 Begins Dosing 64 candidates Azedra TM 64 5 FU leucovorin 64 octreotide implant 64 gastrointestinal mucositis 64 Renal Impairment 64 orally administered synthetic retinoid 64 severe oral mucositis 64 Initiated Phase 64 Acute Lung 64 Aliskiren 64 included exfoliative dermatitis 64 candidate XP# 64 TELINTRA 64 Advanced Melanoma 64 Romiplostim 64 CTAP# Capsules 64 REMINDER ORLive Presents 64 DU #b 64 First Patient Dosed 64 Acute Attacks 64 NDA Submission 64 including thyroiditis RA 64 orally inhaled migraine 64 MAGE A3 ASCI 64 Tambocor 64 Antitumor Activity 64 Severe Sepsis 64 derivatives Radilex TM 64 pralatrexate injection folate analogue 64 Antithrombin 64 sunitinib Sutent ® 64 Metastatic Melanoma 64 CB2 selective receptor agonist 64 Chronic Sinusitis 64 Familial Adenomatous Polyposis FAP 64 Pharmacokinetics PK 64 Européenne Mark 64 Squamous Cell Carcinoma 64 arteriotomy 64 ocular formulation 64 Fidaxomicin 64 invasive candidiasis 64 protein tyrosine phosphatase 1B 64 Simulect 64 Neovascularization 64 humanized interleukin 6 64 Plasmin 64 Intra arterial 64 vidofludimus 64 Tolvaptan 64 Mitral valve 64 AERx ® 64 interferon gamma 1b 64 HGS ETR1 mapatumumab 64 mGluR2 positive 64 systemic juvenile idiopathic 64 vascular occlusive diseases 64 oral anti arrhythmic 64 tumor xenograft models 64 STELARA TM 64 Clolar ® 64 QLT# 64 Cerebril TM 64 MKC# 64 myocardial infarction hypersensitivity 64 AAG geldanamycin analog 64 Bepreve TM 64 Recombinant Human 64 Pegloticase 64 Inhalation Aerosol 64 Sirolimus eluting Coronary Stent 64 tiapamil 64 evaluating tivozanib 64 dual endothelin receptor antagonist 64 Initiates Phase III 64 R brand arformoterol 64 Aurora Kinase 64 Degarelix 64 prescribed proton pump 64 IIa Clinical Trial 64 hyperplasia BPH 64 Proxinium TM 64 corticosteroid dexamethasone 64 NSAID induced 64 Heparin Bioactive Surface 64 volociximab 64 Fludara ® 64 Pegasys ® 64 Angioedema 64 Intravitreal injections 64 Fibrillex TM 64 XL# anticancer compounds 64 posterior uveitis 64 injectable bulking agent 64 HCl PEPCID ® famotidine 64 pseudobulbar affect PBA 64 fallopian tube cancers 64 Preclinical studies suggest 64 urethral bulking agent 64 LHRH receptor positive 64 TLK# 64 targeted nucleotide prodrug 64 Primary Hypercholesterolemia 64 Transdermal Patch 64 infectious diseases autoimmune diseases 64 systemic lupus erythematosus psoriasis 64 recurrent squamous cell carcinoma 64 EUFLEXXA R 64 REVELATION ® 64 Pafuramidine 64 saphenous vein graft 64 Vicinium TM 64 Telik logo TELINTRA 64 cell carcinoma RCC 64 Copegus ® 64 Vidaza ® 64 Oral Calcitonin 64 NMDA antagonist 64 plus GP IIb 64 Paclitaxel Eluting 64 PresbyLens ® 64 BRAF inhibitor 64 antiplatelet compound 64 multicenter randomized placebo controlled 64 PDX pralatrexate 64 Dementia Related Psychosis 64 Kuvan R 64 Granted Orphan Drug 64 PEGINTRON TM 64 Entereg R 64 artificial arteriovenous dialysis 64 Tasigna prolongs 64 assessing T DM1 64 investigational oral inhibitor 64 selective phosphodiesterase 64 ORLive Presents 64 myelofibrosis polycythemia vera 64 non nucleoside inhibitor 64 FEMALES SHOULD BE ADVISED 64 monoclonal antibody conjugated 64 personalized cellular immunotherapy 64 Adenoviral 64 mecarbil 64 Xyfid TM 64 Embolic 64 small molecule tyrosine 64 pain hypotension CVA 64 included neutropenia anemia 64 Medoxomil 64 chronic immune thrombocytopenic 64 Patency 64 Zemiva ™ 64 MEK Inhibitor 64 CRMD# 64 intranasal formulation 64 Xeloda ® 64 Vandetanib 64 TELINTRA R 64 Elotuzumab 64 including acne photodamage 64 medically refractory 63 metastatic pancreatic 63 opioid induced constipation OIC 63 Presents Preclinical Data 63 6R BH4 63 non porcine pancreatic 63 Testosterone MDTS R 63 ELADUR TM 63 Secondary Hyperparathyroidism 63 metastatic castration resistant 63 gastrointestinal disorders characterized 63 selective modulator 63 bullous 63 Unigene nasal calcitonin 63 ribavirin USP 63 metastatic colorectal carcinoma 63 cetuximab Erbitux 63 subcutaneous formulation 63 tiuxetan 63 FOLFOX6 63 venous stasis 63 intravesical infusion therapy 63 Sevelamer 63 Acute Bacterial Sinusitis ABS 63 tumors GIST 63 treat male hypogonadism 63 paroxysmal supraventricular tachycardia 63 Systemic Sclerosis 63 Mg Uk 63 VEGFR2 inhibitor 63 Randomized Clinical Trial 63 Prolongs Survival 63 intra arterial 63 GORE TAG Device 63 alfa 2a 63 superficial basal cell carcinomas 63 aripiprazole Abilify 63 PDE4 inhibitor 63 AEG# 63 treat dysmenorrhea 63 severe hepatomegaly 63 developing Bicifadine serotonin 63 vinca alkaloid 63 rusalatide acetate 63 Kuvan sapropterin dihydrochloride 63 pruritus rash 63 Initiates Clinical 63 Xelox 63 Electronic Brachytherapy System 63 Critical Limb Ischemia 63 KL4 Surfactant 63 Lixivaptan 63 CTO recanalization 63 histone deacetylase HDAC inhibitor 63 MIVI III 63 somatropin Kuvan R 63 phenylalanine ammonia lyase 63 disease GERD 63 symptomatic benign prostatic 63 Controlled Study 63 dots petechiae 63 cardiometabolic diseases Glucophage 63 triggers apoptosis programmed 63 heparin induced thrombocytopenia 63 somatostatin analogue 63 Kinase Inhibitor 63 GAMMAGARD 63 inhibitor RG# 63 Fibrin Pad 63 metastatic androgen independent 63 human C1 inhibitor 63 Shows Statistically Significant 63 refractory chronic lymphocytic 63 Aclidinium 63 distal embolization thrombus formation 63 ALN PCS 63 Diabetic Foot Ulcer 63 ATPace TM 63 R sorafenib tablets 63 HCV NS5B polymerase 63 Motexafin Gadolinium 63 Patients Undergoing 63 Transcatheter 63 gastrointestinal stromal tumors GIST 63 IgG1 monoclonal antibody 63 Overactive Bladder 63 HDAC Inhibitor 63 liposomal formulation 63 Lambert Eaton Myasthenic 63 hormone LHRH antagonist 63 rNAPc2 63 SPL# Gel vaginal microbicide 63 Metabolic Efficiency 63 TRANSDUR ™ 63 Pimavanserin 63 CONTRAINDICATIONS 63 Auxilium transmucosal film 63 thrombophlebitis 63 vein thrombosis 63 Naive Patients 63 Previously Treated 63 Vitrasert ® 63 cromolyn sodium 63 pancreatic gastric 63 Demonstrates Efficacy 63 neuropathic pain spasticity 63 xanthine oxidase inhibitor 63 proprietary polysaccharide 63 Matrix Phase 2b 63 Teriparatide 63 ACTEMRA TM 63 bisoprolol 63 functional mitral regurgitation 63 Initiate Phase III 63 transarterial 63 First Patient Treated 63 DURIN TM 63 octreotide acetate 63 Epidermal Growth Factor Receptor 63 Serostim R 63 Replacement Therapy 63 oxypurinol 63 sitaxsentan 63 plasma kallikrein inhibitor 63 platelet inhibitor 63 Phase IIa Clinical Trial 63 pulmonary alveolar 63 Myoblast 63 cutaneous T 63 multi kinase inhibitor 63 rosuvastatin #mg 63 Diabetic Macular Edema 63 weekly subcutaneous injections 63 sarcoma melanoma 63 Gel repository corticotropin injection 63 Preclinical Data 63 IN PATIENTS WITH 63 Factor Receptor 63 cheilitis 63 Efficacy Results 63 venous stasis ulcers 63 Is Well Tolerated 63 SABER ™ 63 Peginterferon alfa 2b 63 docetaxel Taxotere R 63 Abbott HUMIRA 63 CINTREDEKIN BESUDOTOX 63 interstitial pneumonitis 63 treat atrial flutter 63 hereditary emphysema 63 Soft Tissue Sarcoma 63 rHuPH# recombinant human 63 Phase Ib IIa 63 factor Xa inhibitor 63 OMNARIS HFA 63 Numoisyn Liquid 63 PRT# 63 Advanced Renal Cell 63 direct thrombin inhibitor 63 induce orthostatic hypotension 63 TM Everolimus Eluting 63 Ophena TM 63 ANCA associated 63 vitreous floaters 63 Kit CD# positive 63 Saizen ® 63 post herpetic 63 failure ADHF 63 IMiDs ® 63 ATRA IV 63 SUPPRELIN R LA 63 Presents Positive 63 Ridaforolimus 63 Phase Ib Clinical Trial 63 omega interferon 63 Archexin 63 Ecallantide 63 obstructive lesions 63 lamotrigine Lamictal 63 BENLYSTA ® 63 echinocandin 63 Bosutinib 63 Denufosol 63 Zenvia ™ 63 Parathyroid Hormone 63 fluocinolone acetonide 63 J Am Acad 63 systemic RNAi therapeutic 63 stage IIIb IV 63 SPRYCEL ® 63 congenital ichthyosis 63 ribavirin RBV 63 somatostatin analog 63 Diffuse Large B 63 biliary tract cancer 63 GOUT 63 percutaneous injection 63 gastrointestinal disorders ATI 63 peritumoral brain edema 63 Hylan GF 63 Relapsed Refractory 63 Eprodisate 63 registrational Phase 63 diabetic gastroparesis 63 STARFlex R 63 phase III isavuconazole 63 neovascular diseases 63 rFVIIa 63 metabolic disorders Saizen R 63 cardiac resynchronisation therapy 63 phenyl salicylate methylene blue 63 biologic antibody 63 selective androgen receptor modulator 63 Randomized Evaluation 63 Atypical Hemolytic Uremic Syndrome 63 arteriovenous malformations 63 GW# [003] 63 Gliadel R 63 Erythropoietic therapies may 63 ancrod 63 TAXUS Element Paclitaxel Eluting 63 riociguat 63 Investigational Compound 63 drug zotarolimus 63 p# inhibitor 63 Deforolimus 63 trastuzumab Herceptin R 63 Augment ™ 63 phenylketonuria PKU 63 RhuDex ® 63 Metastatic Colorectal Cancer 63 Microvascular 63 Placebo Controlled 63 Xcytrin R 63 aerosolized KL4 surfactant 63 peptidic compound 63 Tumour Vascular Disrupting Agent 63 anterior uveitis 63 immuno inflammatory diseases 63 polyneuropathy HIV DSP 63 Oral Mucositis 63 Novartis Reclast 63 PEGylated 63 PI3K/Akt pathway inhibitor 63 Randomized Study 63 severe gastroparesis 63 Soliris eculizumab 63 humanised monoclonal antibody 63 lintuzumab SGN 63 hemorrhagic cerebrovascular events 63 Microwave Ablation System 63 By JENNIFER LEARN 63 EVIZON ™ 63 Alvine Pharmaceuticals 63 IND Application 63 ara C 62 irregular quivering 62 Tocilizumab 62 Vascular Grafts 62 Sezary syndrome 62 humanized monoclonal 62 ADL# novel 62 Dacogen decitabine 62 terlipressin 62 Retisert ® 62 Advancing Drugs 62 Acute Myocardial Infarction 62 Abrupt discontinuation 62 inhalation powder 62 immunomodulatory therapy 62 selective antagonist 62 neutropenia dehydration dyspnea 62 thalidomide Thalomid 62 lanreotide 62 targeted antifolate 62 cetrorelix pamoate 62 Amigal TM 62 factor Xa 62 Adenoscan R 62 Phase Ib clinical trials 62 oral antidiabetic medication 62 dopamine receptor agonist 62 Tacrolimus 62 Phase IIb clinical trials 62 atypical hemolytic uremic syndrome 62 rheumatoid arthritis osteoarthritis ankylosing 62 oncolytic virus therapies 62 cell lymphoma CTCL 62 NeoLipid R 62 DexaSite 62 Exherin TM 62 Single Dose 62 clot retrieval 62 Myocardial Infarction Study 62 relapsing multiple sclerosis 62 Unit Dose Budesonide 62 de novo kidney transplant 62 Cleviprex TM clevidipine 62 unresectable stage 62 Mitomycin C 62 endovascular stent graft 62 transplantation HCT 62 ILUVIEN ® 62 Perforomist ™ Inhalation Solution 62 diaper dermatitis complicated 62 Panzem NCD 62 Aurexis R 62 Temsirolimus 62 Onalta TM 62 Unstable Angina 62 include Phenoptin TM 62 Omacetaxine 62 Dasatinib 62 Occlusion 62 Ofatumumab 62 IV NSCLC 62 Stenosis 62 intravenous methylnaltrexone 62 Eluting Coronary Stent System 62 Confirmatory Phase 62 Polyzene R F 62 plus Copegus R 62 erythematosus 62 AzaSite Plus 62 XOPENEX R 62 MetroGel 62 Alfacell proprietary ribonuclease 62 stent DES 62 Sciences ABthrax Albuferon 62 Cardiac Resynchronization Therapy 62 oral Janus kinase 62 ST Elevation Myocardial 62 ODT metoclopramide HCl PEPCID 62 Telithromycin 62 RhuDex R 62 Host Disease 62 AERx R 62 Lactic acidosis 62 morphometric vertebral fractures 62 novel histone deacetylase 62 Lenocta TM 62 factor Xa inhibitors 62 Luveris R Ovidrel R 62 basiliximab 62 descending thoracic aorta 62 verteporfin 62 XEN# 62 ATTR PN 62 Dosa suffers 62 cilengitide 62 corneal inlay 62 oropharyngeal candidiasis 62 pioglitazone HCl 62 POLYSHIELD ® POLYCLEAR ® 62 inhaled formulation 62 castrate resistant prostate cancer 62 GP IIb IIIa inhibitors 62 bleeding pallor 62 ALVESCO R 62 ATS Simulus R 62 FDA Accepts 62 ischemic mitral regurgitation 62 herpetic keratitis 62 PROTEGE 62 diabetic macular edema DME 62 A1PI 62 PROSTASCINT R 62 infections cIAI 62 Pulmonary Embolism PE 62 TTR amyloidosis 62 adalimumab Humira 62 JAK2 Inhibitor 62 Kepivance 62 SAR# [002] 62 Carotid 62 leukemia AML 62 mTOR inhibitor 62 OAB overactive bladder 62 relapsing remitting MS RRMS 62 antifibrotic 62 VALSTAR TM 62 Granulocyte Colony Stimulating Factor 62 Zemiva TM 62 cancer mCRC 62 Prodrug 62 Shellgel TM injectable viscoelastic 62 candidates Azedra 62 Unfractionated Heparin 62 Diovan Exforge Tekturna Zelnorm 62 nosocomial pneumonia 62 Diabetic Foot Ulcers 62 underlying vasculopathy 62 FOLFOX6 chemotherapy regimen 62 Lymphocytic 62 metformin HCl 62 selective immunoproteasome inhibitor 62 Duodenal 62 neovascular wet age 62 Cardiac Resynchronization 62 pain palliation 62 salmeterol fluticasone 62 ischemia driven 62 THR beta agonist 62 Chemokine Receptor 62 systemic fungal infections 62 RANK Ligand inhibitor 62 ThermoDox R 62 NEBIDO R 62 Known generically 62 Dural Regeneration Matrix 62 unfractionated heparin UFH 62 Critical Limb Ischemia CLI 62 Pyridorin 62 Tarceva TM 62 clevidipine 62 WRX STi +# mins 62 lead Aganocide compound 62 Solution XOPENEX HFA 62 Metastatic Prostate Cancer 62 cediranib 62 arthropathy 62 ACV1 62 Atherosclerotic 62 5 HT4 62 CIMZIA R 62 IMA# 62 pathophysiological effects 62 armodafinil Tablets C 62 longus tendon 62 Septal 62 nilotinib Tasigna ® 62 lenalidomide Revlimid R 62 inhalation aerosol 62 amikacin 62 ELACYT 62 POSIDUR TM ELADUR TM 62 Acute Myocardial 62 formerly LymphoStat B 62 Enzyme Replacement Therapy 62 Xanafide 62 CINQUIL 62 candidates Augment ™ 62 Topical Suspension 62 IIIa inhibitor 62 Cardium Therapeutics TM 62 Second Pivotal Phase